Drugs with fewest side-effects for treating irritable bowel syndrome identified, study suggests
Monday, March 26, 2012 - 23:30
in Health & Medicine
Researchers have determined that two prevalent drug therapies -- rifaximin and lubiprostone -- offer some of the best options for treating irritable bowel syndrome, a widespread disorder that affects up to one in five Americans. The findings are based on an analysis of more than two dozen large-scale clinical trials.